Skip to main content
. 2014 Mar 16;2014:475175. doi: 10.1155/2014/475175

Table 3.

Comparison of published reports on patients with brain metastases from chondrosarcoma and chordoma.

Case author Age, sex IB yr. BM treatment OS Mo
Chondrosarcoma
Flannery et al., 2010 [15] 14 M, 56 M 0.5–1.3 GKSRS 18–21
Francés-Muñoz et al., 2012 [39] 53 F 10 Chemo for lung NR
Kawaguchi et al., 2012 [43] 54 M 0.7 Chemo 52
Jallu et al., 1992 [41] 54 F 0.7 SR NR
Konishi et al., 1994 [44] 72 F 2 SR 2
Reyaz and Ashraf, 2006 [45] 34 F 7 SR NR
Talerman, 1967 [46] 26 F
Templeton et al., 1985 [47] 15 M 34 D NR
Waga et al., 1972 [48] 32 M 12 SR NR
Tsutsumi et al., 2010 [40] 60 M 4.4 Chemo, GKSRS 10+
Fox et al., 1968 [49] 51 F D 11

Chordoma
Kamel et al., 2005 [53] 12 M 32 SR 32 (alive)
Anderson and Meyers, 1968 [54] 69 M 24 SR (gross total) 36 (alive)
Al-Adra et al., 2011 [52] 29 M 16 SR, WBRT ?
Morris and Rabinovitch, 1947 [56] 41 M 2.5 WBRT 2.5
Fichardt and De Villiers, 1974 [55] 59 M 36 SR 42
Higinbotham et al. 1967 [50] 58 F ? None (autopsy finding) 72
Mesgarzadeh et al., 2008 [57] 27 F 18 None 24

Chemo: chemotherapy; D: death prior to treatment; F: female; GKSRS: Gamma knife stereotactic radiosurgery; IB: interval between diagnosis of brain metastasis from chondrosarcoma in years (yr); M: male; NR: not reported; OS: overall survival in months; Radio: radiotherapy; SR: surgical resection; WBRT: whole brain radiotherapy; adiagnosed postmortem; bbrain metastasis diagnosed first; +: survival reported for at least the stated amount.